318 related articles for article (PubMed ID: 27121846)
21. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
22. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
[TBL] [Abstract][Full Text] [Related]
25. Minimal hepatic encephalopathy.
Dhiman RK; Chawla YK
Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
[TBL] [Abstract][Full Text] [Related]
26. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.
Mancini A; Campagna F; Amodio P; Tuohy KM
Food Funct; 2018 Mar; 9(3):1373-1388. PubMed ID: 29485654
[TBL] [Abstract][Full Text] [Related]
27. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
28. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
29. Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis.
Xia X; Chen J; Xia J; Wang B; Liu H; Yang L; Wang Y; Ling Z
J Int Med Res; 2018 Sep; 46(9):3596-3604. PubMed ID: 29806520
[TBL] [Abstract][Full Text] [Related]
30. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
[TBL] [Abstract][Full Text] [Related]
31. Nonpharmacologic Management of Hepatic Encephalopathy: An Update.
Weir V; Reddy KR
Clin Liver Dis; 2020 May; 24(2):243-261. PubMed ID: 32245531
[TBL] [Abstract][Full Text] [Related]
32. Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy.
Shavakhi A; Hashemi H; Tabesh E; Derakhshan Z; Farzamnia S; Meshkinfar S; Shavakhi S; Minakari M; Gholamrezaei A
J Res Med Sci; 2014 Aug; 19(8):703-8. PubMed ID: 25422653
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of microbiome therapies for hepatic encephalopathy.
Gao J; Nie R; Chang H; Yang W; Ren Q
Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):927-937. PubMed ID: 37505972
[TBL] [Abstract][Full Text] [Related]
34. Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: a realistic hope?
Sekhar MS; Unnikrishnan MK; Rodrigues GS; Mukhopadhyay C
Med Hypotheses; 2013 Aug; 81(2):167-8. PubMed ID: 23759357
[TBL] [Abstract][Full Text] [Related]
35. Management of Hepatic Encephalopathy: A Primer.
Jawaro T; Yang A; Dixit D; Bridgeman MB
Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
[TBL] [Abstract][Full Text] [Related]
36. Optimal treatment of hepatic encephalopathy.
Waghray A; Waghray N; Kanna S; Mullen K
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
[TBL] [Abstract][Full Text] [Related]
37. Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment.
Shi J; Li F
Eur J Gastroenterol Hepatol; 2023 Jul; 35(7):777-781. PubMed ID: 37161982
[TBL] [Abstract][Full Text] [Related]
38. Hepatic encephalopathy.
Khungar V; Poordad F
Clin Liver Dis; 2012 May; 16(2):301-20. PubMed ID: 22541700
[TBL] [Abstract][Full Text] [Related]
39. Diet and cognition in chronic liver disease.
Kachaamy T; Bajaj JS
Curr Opin Gastroenterol; 2011 Mar; 27(2):174-9. PubMed ID: 20975555
[TBL] [Abstract][Full Text] [Related]
40. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
